Onxeo
Recorded as renamed to Valerio Therapeutics (2023)
When these terms end
Fee deadlines
No maintenance fee falls due on this company's record before Nov 19, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
No patent on this record is in force and held under this name now.
Sources and methods
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 2 abandoned · 3 no status recorded
Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/007,768 | Jun 4, 2021 | No status recorded | |
| 17/038,704 | Treatment of Cancer by Systemic Administration of Dbait Molecules | Sep 30, 2020 | Abandoned |
| 17/593,474 | Mar 19, 2020 | No status recorded | |
| 17/414,342 | Dec 20, 2019 | No status recorded | |
| 16/979,892 | A Dbait Molecule Against Acquired Resistance in the Treatment of Cancer | Mar 12, 2019 | Abandoned |
| 16/078,706 | Combination Therapies Comprising Immuno-Oncology Agents and Belinostat | Feb 22, 2017 | Pending |